Method for producing eritadenine in liquid phase fermentation

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing heterocyclic carbon compound having only o – n – s,...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S277000, C435S254100

Reexamination Certificate

active

08053217

ABSTRACT:
Method to produce eritadenine by liquid phase fermentation ofLentinus edodeswithout formation of the fruit body wherein theLentinus edodesis exposed to shear during its cultivation.

REFERENCES:
patent: 0 191 607 (1986-08-01), None
Lelik et al., “Production of the mycelium of shiitake (Lentinus edodes) mushroom and investigation of its bioactive compounds,” 26(3):271-277, 1997.
Hassegawa, R. et al., “Growth and antibacterial activity ofLentinula edodesin liguid media supplemented with agricultural wastes,” Journal of Biotechnology, Issue of Aug. 15, Accepted Mar. 15, 2005, vol. 8, No. 2, p. 212-217.
Enman, J. et al, “Production of the Bioactive Compound Eritadenine by Submerged Cultivation of Shiitake (Lentinus edodes) Mycelia,” J. Agric. Food Chem., 2008, vol. 56, pp. 2609-2612.
Kabir, Y.et al, “Dietary Mushrooms Reduce Blood-Pressure in Spontaneously Hypertensive Rats” (SHR). J. Nutr. Sci. Vitaminol. 1989, vol. 35, No. 1, pp. 91-94.
Kabir, Y. et al, “Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats,” J. Nutr. Sci. Vitaminol. 1987, vol. 33, No. 5, pp. 341-346.
Kaneda, T. et al, “Effect of various mushroom preparations on cholesterol levels in rats,” J. Nutr. 1966, vol. 90, pp. 371-376.
Suzuki, S. et al, “Influence of shiitake (Lentinus edodes) on human serum cholesterol,” Mushroom Sci. 1974, vol. 9, 463-467.
Chibata, I. et al, “Lentinacin: a new hypocholesterolemic substance inLentinus edodes”. Experientia 25/12, 1969, 1237-1238.
Kamiya, T. et al, “Structure and syn-thesis of lentysine, a new hypocholesterolemic substance,” Tetrahedron Letters 1969, vol. 10, No. 53, pp. 4729-4732.
Tokita, F. et al, “Isolation and chemical structure of the plasma-cholesterol reducing substances from shiitake mushroom,” Mushroom Sci. 1972, vol. 8, pp. 783-787.
Rokujo, T. et al, “Lentysine: a new hypolipidemic agent from a mushroom,” Life Sci. 1970, vol. 9, pp. 379-385.
Shimada, Y. et al, “Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets,” Biosci. Biotechnol. Biochem. 2003, vol. 67, pp. 996-1006.
Shimada, Y. et al, “Dietary eritadenine and ethanolamine depress fatty acid desaturase activities by increasing liver microsomal phosphatidylethanolamine in rats,” J. Nutr. 2003, vol. 133, pp. 758-765.
Shimada, Y. et al, “Effects of dietary eritadenine on the liver microsomal Δ 6-desaturase activity and its mRNA in rats,” Biosci. Biotechnol. Biochem., 2003, vol. 67, pp. 1258-1266.
Sugiyama, K. et al, “Eritadenine-induced alteration of hepatic phospholipid-metabolism in relation to its hypocholes-terolemic action in rats,” J. Nutr. Biochem. 1995, vol. 6, pp. 80-87.
Sugiyama, K. et al, “Dietary eritadenine modifies plasma phosphatidylcholine molecular species profile in rats fed different types of fat”. J. Nutr. 1997, vol. 127, 593-599.
Takashima, K. et al, “The hypocho-lesterolemic action of eritadenine in the rat,” Atherosclerosis. 1973, vol. 17, pp. 491-502.
Takashima, K. et al, “Effect of eritadenine on cholesterol metabolism in the rat,” Biochem. Phar-macol. 1974, vol. 23, pp. 433-438.
Votruba, I. et al, “Eritadenine—novel type of potent inhibitors of S-adenosyl-L-homocysteine hydrolase,” Collect. Czech. Chem. Commun. 1982, vol. 47, pp. 167-172.
Schanche, J. et al, “The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes,” Mol. Pharma-col. 1984, vol. 26, pp. 553-558.
Saito, M. et al, “Quantitative analyses of eri-tadenine in shiitake mushroom and other edible fungi,” J. Jap. Soc. Food Nutr. 1975, vol. 28, pp. 503-513. (English abstract).
Vitanyi, G. et al, “Detection of eritadenine in extracts from shii-take mushroom by gas chromatography mass spectrometry,” Rapid Com-mun. Mass Spectrom. 1998, vol. 12, pp. 120-122.
Enman, J. et al, “Quantification of the bioac-tive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes)”, J. Agric. Food. Chem. 2007, vol. 55, No. 4, pp. 1177-1180.
Leonard, N. J. et al, “5-amino-5-deoxyribose deriva-tives. Synthesis and use in the preparation of reversed nucleosides”, J. Heterocycl. Chem. 1966, vol. 3, pp. 485-489.
Levene, P. A. et al, “Acetone Derivatives of d-Ribose,” J. Biol. Chem. 1934, vol. 106, pp. 421-429.
Kawazu, M. et al, “Studies on the oxidation of reversed nucleosides in oxygen. I. Synthesis of eritadenine and its derivatives,” J. Organ.. Chem. 1973, vol. 38, pp. 2887-2890.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for producing eritadenine in liquid phase fermentation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for producing eritadenine in liquid phase fermentation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing eritadenine in liquid phase fermentation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4291193

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.